Alirocumab 150mg/1ml solution for injection pre-filled disposable devices
NHS hospitals in England used £15,646,176 of indicative cost of Alirocumab 150mg/1ml solution for injection pre-filled disposable devices in the 12 months to July 2026, about 0.1% of all hospital medicines spend. That is up 6.1% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Alirocumab 150mg/1ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Alirocumab 150mg/1ml solution for injection pre-filled disposable devices most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| University Hpls Of Leicester Nhs Trust | £843,024 |
| Univ Hpl B/Ham Nhs Foundation Trust | £607,488 |
| Barts Health Nhs Trust | £591,864 |
| Guy's & St Thomas' Nhs Foundation Trust | £587,496 |
| Walsall Healthcare Nhs Trust | £477,288 |
| Leeds Teaching Hpls Nhs Trust | £418,320 |
| Aintree University Hospital Nhs Ft | £410,928 |
| Oxford University Hospitals Nhs Ft | £404,712 |
| Hampshire Hospitals Nhs Foundation Trust | £403,872 |
| Western Sussex Hospitals Nhs Found Trust | £396,480 |
The primary-care picture
Alirocumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Alirocumab medicine page.